Reed's (REED)
Market Price (2/11/2026): $2.01 | Market Cap: $16.6 MilSector: Consumer Staples | Industry: Soft Drinks & Non-alcoholic Beverages
Reed's (REED)
Market Price (2/11/2026): $2.01Market Cap: $16.6 MilSector: Consumer StaplesIndustry: Soft Drinks & Non-alcoholic Beverages
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Megatrend and thematic driversMegatrends include Health & Wellness Trends. Themes include Functional Foods & Beverages, and Organic & Natural Products. | Weak multi-year price returns2Y Excs Rtn is -122%, 3Y Excs Rtn is -160% | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -15 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -42% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -9.0%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -10% | ||
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -47%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -48% | ||
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 114% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -98% | ||
| High stock price volatilityVol 12M is 139% | ||
| Key risksREED key risks include [1] its precarious financial health, Show more. |
| Megatrend and thematic driversMegatrends include Health & Wellness Trends. Themes include Functional Foods & Beverages, and Organic & Natural Products. |
| Weak multi-year price returns2Y Excs Rtn is -122%, 3Y Excs Rtn is -160% |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -15 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -42% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -9.0%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -10% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -47%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -48% |
| Valuation getting more expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is 114% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -98% |
| High stock price volatilityVol 12M is 139% |
| Key risksREED key risks include [1] its precarious financial health, Show more. |
Qualitative Assessment
AI Analysis | Feedback
Reed's (REED) stock has lost about 85% since 10/31/2025 because of the following key factors:
1. Continued Financial Losses and Weak Operating Performance.
Reed's reported a net loss of $4.0 million, or -$0.48 per share, for the third quarter of 2025, alongside a modified EBITDA loss of $3.9 million. The company also utilized $2.8 million in cash from operating activities during this period, and as of September 30, 2025, held $4.1 million in cash against $9.2 million in total debt. While net sales saw a modest 4% increase to $7.0 million, and gross profit remained flat, the gross margin slightly declined to 17% due to inventory write-offs, and selling, general, and administrative expenses rose to $4.2 million. These figures signaled ongoing financial instability and a struggle to achieve profitability.
2. Reverse Stock Split.
Effective November 3, 2025, Reed's common stock began trading on the OTCQX Best Market on a split-adjusted basis. Reverse stock splits are typically implemented to artificially increase a company's share price to meet listing requirements or appeal to a broader investor base. However, they frequently fail to address underlying financial issues and can erode investor confidence, often leading to further stock price declines as the market reacts to the lack of fundamental improvement following the split. The stock price of $12.00 on October 31, 2025, preceding the split's effective date, significantly decreased in the subsequent period.
Show more
1. Continued Financial Losses and Weak Operating Performance.
Reed's reported a net loss of $4.0 million, or -$0.48 per share, for the third quarter of 2025, alongside a modified EBITDA loss of $3.9 million. The company also utilized $2.8 million in cash from operating activities during this period, and as of September 30, 2025, held $4.1 million in cash against $9.2 million in total debt. While net sales saw a modest 4% increase to $7.0 million, and gross profit remained flat, the gross margin slightly declined to 17% due to inventory write-offs, and selling, general, and administrative expenses rose to $4.2 million. These figures signaled ongoing financial instability and a struggle to achieve profitability.
2. Reverse Stock Split.
Effective November 3, 2025, Reed's common stock began trading on the OTCQX Best Market on a split-adjusted basis. Reverse stock splits are typically implemented to artificially increase a company's share price to meet listing requirements or appeal to a broader investor base. However, they frequently fail to address underlying financial issues and can erode investor confidence, often leading to further stock price declines as the market reacts to the lack of fundamental improvement following the split. The stock price of $12.00 on October 31, 2025, preceding the split's effective date, significantly decreased in the subsequent period.
Show more
Stock Movement Drivers
Fundamental Drivers
The -82.7% change in REED stock from 10/31/2025 to 2/10/2026 was primarily driven by a -81.6% change in the company's P/S Multiple.| (LTM values as of) | 10312025 | 2102026 | Change |
|---|---|---|---|
| Stock Price ($) | 12.00 | 2.08 | -82.7% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 36 | 36 | 0.8% |
| P/S Multiple | 2.6 | 0.5 | -81.6% |
| Shares Outstanding (Mil) | 8 | 8 | -6.3% |
| Cumulative Contribution | -82.7% |
Market Drivers
10/31/2025 to 2/10/2026| Return | Correlation | |
|---|---|---|
| REED | -82.7% | |
| Market (SPY) | 1.5% | 14.4% |
| Sector (XLP) | 14.3% | -3.8% |
Fundamental Drivers
The -65.3% change in REED stock from 7/31/2025 to 2/10/2026 was primarily driven by a -60.0% change in the company's P/S Multiple.| (LTM values as of) | 7312025 | 2102026 | Change |
|---|---|---|---|
| Stock Price ($) | 6.00 | 2.08 | -65.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 38 | 36 | -5.4% |
| P/S Multiple | 1.2 | 0.5 | -60.0% |
| Shares Outstanding (Mil) | 8 | 8 | -8.3% |
| Cumulative Contribution | -65.3% |
Market Drivers
7/31/2025 to 2/10/2026| Return | Correlation | |
|---|---|---|
| REED | -65.3% | |
| Market (SPY) | 9.8% | 12.6% |
| Sector (XLP) | 10.0% | -5.0% |
Fundamental Drivers
The -71.1% change in REED stock from 1/31/2025 to 2/10/2026 was primarily driven by a -89.8% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 1312025 | 2102026 | Change |
|---|---|---|---|
| Stock Price ($) | 7.20 | 2.08 | -71.1% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 40 | 36 | -9.0% |
| P/S Multiple | 0.2 | 0.5 | 210.1% |
| Shares Outstanding (Mil) | 1 | 8 | -89.8% |
| Cumulative Contribution | -71.1% |
Market Drivers
1/31/2025 to 2/10/2026| Return | Correlation | |
|---|---|---|
| REED | -71.1% | |
| Market (SPY) | 16.0% | 8.5% |
| Sector (XLP) | 12.5% | 0.9% |
Fundamental Drivers
The -90.5% change in REED stock from 1/31/2023 to 2/10/2026 was primarily driven by a -95.4% change in the company's Shares Outstanding (Mil).| (LTM values as of) | 1312023 | 2102026 | Change |
|---|---|---|---|
| Stock Price ($) | 21.96 | 2.08 | -90.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 51 | 36 | -28.5% |
| P/S Multiple | 0.2 | 0.5 | 190.7% |
| Shares Outstanding (Mil) | 0 | 8 | -95.4% |
| Cumulative Contribution | -90.5% |
Market Drivers
1/31/2023 to 2/10/2026| Return | Correlation | |
|---|---|---|
| REED | -90.5% | |
| Market (SPY) | 76.6% | 1.5% |
| Sector (XLP) | 27.1% | 0.7% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| REED Return | -39% | -81% | -99% | -61% | -44% | 2% | -100% |
| Peers Return | 3% | -5% | -11% | 20% | -13% | 2% | -7% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 2% | 85% |
Monthly Win Rates [3] | |||||||
| REED Win Rate | 50% | 33% | 33% | 42% | 58% | 50% | |
| Peers Win Rate | 47% | 48% | 48% | 48% | 47% | 70% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 100% | |
Max Drawdowns [4] | |||||||
| REED Max Drawdown | -41% | -81% | -99% | -63% | -44% | -3% | |
| Peers Max Drawdown | -17% | -22% | -23% | -21% | -23% | -8% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: ZVIA, FIZZ, KDP, PEP, KO.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 2/10/2026 (YTD)
How Low Can It Go
| Event | REED | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -83.1% | -25.4% |
| % Gain to Breakeven | 492.9% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -64.9% | -33.9% |
| % Gain to Breakeven | 185.0% | 51.3% |
| Time to Breakeven | 77 days | 148 days |
| 2018 Correction | ||
| % Loss | -41.9% | -19.8% |
| % Gain to Breakeven | 72.2% | 24.7% |
| Time to Breakeven | 128 days | 120 days |
| 2008 Global Financial Crisis | ||
| % Loss | -89.8% | -56.8% |
| % Gain to Breakeven | 878.5% | 131.3% |
| Time to Breakeven | 1,312 days | 1,480 days |
Compare to ZVIA, FIZZ, KDP, PEP, KO
In The Past
Reed's's stock fell -83.1% during the 2022 Inflation Shock from a high on 1/4/2022. A -83.1% loss requires a 492.9% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About Reed's (REED)
Reed's, Inc. engages in the manufacture and distribution of natural hand-crafted beverages in the craft specialty foods industry in the United States, Canada, Asia, Europe, Australia, and South America. It offers Reed's craft ginger beers; Reed's real ginger ales; Reed's ready to drink products; Virgil's handcrafted sodas; ginger candy; and other ginger beverages under the Reed's brand. Reed's, Inc. sells its products to natural food and gourmet retailers, grocery store chains, mass merchants, club stores, convenience and drug stores, liquor stores, industrial cafeterias, and on-premise bars and restaurants through distributors and independent distributor partners, as well as direct to store distribution. It also exports its products to France, the United Kingdom, South Africa, the Caribbean, Canada, Spain, the Philippines, Israel, Australia, Asia, rest of Europe, and South America. The company was formerly known as Original Beverage Corporation and changed its name to Reed's, Inc. in 2001. Reed's, Inc. was founded in 1987 and is headquartered in Norwalk, Connecticut.
AI Analysis | Feedback
```html- Boston Beer Company for craft sodas.
- Honest Tea for ginger beer and craft sodas.
- Chobani for specialty sodas.
AI Analysis | Feedback
- Reed's Ginger Beer: A line of ginger-based carbonated beverages, including both non-alcoholic and alcoholic options.
- Virgil's Craft Sodas: A collection of all-natural, handcrafted sodas featuring flavors like root beer, cream soda, and black cherry.
- Flying Cauldron Butterscotch Beer: A non-alcoholic, cream soda-like beverage with a distinct butterscotch flavor.
AI Analysis | Feedback
Reed's (symbol: REED) primarily sells its products to other companies, specifically retailers and distributors, rather than directly to individuals. Based on the company's public filings, its major customers include:
- Kroger (symbol: KR)
- Walmart (symbol: WMT)
- Target (symbol: TGT)
- Publix (privately held)
- Whole Foods Market (owned by Amazon, symbol: AMZN)
- Costco (symbol: COST)
AI Analysis | Feedback
Niagara Bottling, LLC
AI Analysis | Feedback
Cyril Wallace, Chief Executive Officer & Director
Mr. Wallace was appointed Chief Executive Officer and Director in April 2025. Prior to joining Reed's, he served as Vice President and General Manager for PepsiCo Beverages North America, where he oversaw a $3.2 billion business unit spanning sales, operations, and go-to-market strategy. He previously led PepsiCo's Atlantic Region as Sales Vice President and General Manager, managing a $2.7 billion territory and more than 4,000 employees. He has over two decades of experience in senior leadership roles at PepsiCo.
Douglas McCurdy, Chief Financial Officer
Mr. McCurdy was appointed Chief Financial Officer in February 2025. Before joining Reed's, he served as Chief Financial Officer and Chief Operating Officer at several early-stage growth companies, including REZI, Torrential, and BBE. He also held corporate finance and strategic advisory positions at Banc of America Securities and began his career as a Lieutenant in the U.S. Navy.
Christopher J. Reed, Founder, Chief Innovation Officer & Director
Mr. Reed founded Reed's Inc. in 1989. He transitioned to the role of Chief Innovation Officer in April 2017.
Salvatore Vassallo, Vice President of Operations
Mr. Vassallo was appointed Vice President of Operations in February 2025. Prior to joining Reed's, he served as Vice President of Supply Chain at Boylan Bottling Co. His experience in supply chain management for consumer packaged goods (CPG) companies also includes key roles at Ferrero, Snapple Beverages, and Henkel.
Neal Cohane, Chief Sales Officer
Mr. Cohane serves as the Chief Sales Officer for Reed's. He has also been noted as the Senior Vice President of Sales & Marketing.
AI Analysis | Feedback
The key risks to Reed's (REED) business include its financial health and liquidity, its dependence on third-party manufacturing and supply chain, and intense competition within the beverage industry.
- Financial Health and Liquidity: Reed's faces significant challenges related to its financial health, including a high debt-to-equity ratio of 332.2%. The company has less than a year of cash runway based on its current free cash flow and if free cash flow continues to grow at historical rates. Furthermore, Reed's has struggled with profitability, reporting a flat gross profit and a slight decrease in gross margin, attributed to inventory write-offs, and a widening modified EBITDA loss. These factors indicate potential difficulties in generating adequate gross income and maintaining financial stability.
- Dependence on Third-Party Manufacturing and Supply Chain: The company relies heavily on co-packers to manufacture its products. Risks associated with this dependency include the potential failure of co-packers to produce products on a timely basis or at all, challenges in securing suitable arrangements and sufficient co-packing capacity, and difficulties in replacing discontinued co-packing arrangements. Any disruptions in this area could significantly impact product availability and operational costs.
- Intense Competition and Market Position: Reed's operates in a highly competitive beverage market, which subjects the company to competitive products, pricing pressures, and challenges in maintaining or gaining market share. The ability to implement and sustain price increases, as well as the effectiveness of advertising, marketing, and promotional strategies, are critical in this environment and pose ongoing risks to the business.
AI Analysis | Feedback
The rapid emergence and market penetration of functional beverages, particularly "prebiotic sodas" such as Poppi and Olipop, pose a clear emerging threat to Reed's. These brands directly compete for health-conscious consumers who seek natural, flavorful, and often lower-sugar alternatives to traditional sodas. Unlike Reed's ginger beers, which primarily offer refreshment and natural ingredients, these newer functional sodas provide an additional perceived health benefit (e.g., gut health), often with significantly reduced sugar content, aligning with evolving consumer preferences for wellness-driven beverages.
AI Analysis | Feedback
The addressable markets for Reed's main products and services in the U.S. are as follows:
- Ginger Beer: The global ginger beer market was valued at approximately USD 5.2 billion in 2023 and is projected to reach USD 9.64 billion by 2032, growing at a CAGR of 7.1% from 2025 to 2032. North America dominates the global ginger beer market, with the United States being the largest market in the region. Another estimate places the ginger beer market at USD 5.89 billion in 2025, expanding to USD 8.60 billion by 2030 with a CAGR of 7.27%.
- Ginger Ale: The U.S. ginger ale market was a USD 1.5 billion market as of 2022. The Ginger Ale Market Size is forecast to reach USD 4593.2 Million (USD 4.59 billion) by 2030, with a CAGR of 3.7% during the forecast period of 2024-2030.
- Kombucha: The U.S. kombucha market generated an estimated revenue of USD 1,616.8 million in 2024 and is anticipated to reach USD 5,124.6 million by 2033, demonstrating a CAGR of 13.7% from 2025 to 2033. Another assessment values the U.S. Kombucha Market at approximately USD 1.6 billion. The U.S. kombucha market is projected to grow from USD 1,328.67 million in 2023 to an estimated USD 4,936.48 million by 2032, with a CAGR of 15.70%.
- Functional Beverages (U.S.): Reed's products, particularly ginger beer and kombucha, fall under the broader functional beverage market. The U.S. functional beverages market size is evaluated at USD 51.84 billion in 2025 and is predicted to be worth around USD 93.07 billion by 2034, rising at a CAGR of 6.70% from 2025 to 2034.
- Ready-to-Drink (RTD) Beverages (U.S.): Reed's offers ready-to-drink products. The U.S. ready-to-drink beverages market size is projected to reach USD 247.26 billion by 2032. The ready-to-drink beverages market size, valued at USD 380.46 billion in 2025, is projected to surge to USD 481.88 billion by 2030, marking a steady CAGR of 4.84%.
- Virgil's Handcrafted Sodas: null
- Ginger Candies: null
AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for Reed's (REED) over the next 2-3 years:
- Expansion of Distribution and Customer Growth: Reed's is actively securing new distribution deals with major national retailers, including recent wins with Costco, Kroger, and Walgreens for product tests. This expansion into new retail channels and strengthening relationships with existing recurring national customers are expected to drive increased product availability and reach a broader consumer base.
- Launch and Restaging of New Products/Product Portfolio Optimization: The company has recently launched a new functional soda line and plans to further expand its product portfolio in 2025. Additionally, Reed's intends to restage its core and functional product lines with major relaunches slated for mid-2026. These initiatives aim to innovate and refresh offerings, attracting new consumers and potentially increasing sales from existing customers.
- Operational Efficiencies Leading to Enhanced Competitiveness: While not a direct revenue driver, Reed's focus on optimizing operations, improving margins, and undertaking inventory rationalization, including shifting primary SKUs from glass to cans, is anticipated to yield cost and margin benefits through 2026. These efficiencies can enhance the company's competitiveness and ability to reinvest in growth initiatives, thereby indirectly supporting revenue expansion.
AI Analysis | Feedback
Share Repurchases
No information available.
Share Issuance
- Reed's closed a $10.0 million private placement on December 30, 2024, issuing approximately 14.7 million shares of common stock at $0.68 per share.
- On September 15, 2025, the company completed a $5.0 million private investment in public equity (PIPE) financing, selling 5 million shares of common stock at $1.00 per share.
- A primary offering of 1,326,260 shares of common stock was filed on November 12, 2025, with estimated net proceeds of about $9.0 million (potentially $10.4 million if the over-allotment option is exercised) at an assumed price of $7.54.
Inbound Investments
- On December 30, 2024, Reed's closed a $10.0 million PIPE financing, with capital earmarked for growth strategies including potential M&A opportunities, strategic partnerships, and international expansion.
- Reed's secured $6 million in PIPE financing on September 16, 2024, which included $1.9 million in cash proceeds from its largest stockholder, D&D Source of Life Holding LTD.
- In May 2023, the company closed $5.6 million in financing, which notably included a $4.1 million PIPE issuance led by D&D Source of Life Holding LTD, a Hong Kong-based investment company, forming a strategic alliance for market expansion.
Outbound Investments
- Reed's has indicated plans to pursue accretive M&A opportunities and strategic partnerships, utilizing capital from recent financings to support these efforts.
Capital Expenditures
- Capital expenditures were low, with the purchase of property and equipment totaling $0.101 million in 2021 and $0.095 million in 2022.
- The company adopts an asset-light operational model by outsourcing manufacturing, which minimizes the need for substantial capital investments in production facilities.
- Funds are primarily allocated towards increasing finished goods inventory, marketing, and improving working capital rather than large-scale fixed asset investments.
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 32.05 |
| Mkt Cap | 21.2 |
| Rev LTM | 8,687 |
| Op Inc LTM | 1,856 |
| FCF LTM | 878 |
| FCF 3Y Avg | 748 |
| CFO LTM | 1,160 |
| CFO 3Y Avg | 1,022 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 2.5% |
| Rev Chg 3Y Avg | 2.0% |
| Rev Chg Q | 5.3% |
| QoQ Delta Rev Chg LTM | 1.5% |
| Op Mgn LTM | 17.1% |
| Op Mgn 3Y Avg | 16.6% |
| QoQ Delta Op Mgn LTM | 0.1% |
| CFO/Rev LTM | 13.0% |
| CFO/Rev 3Y Avg | 12.9% |
| FCF/Rev LTM | 9.0% |
| FCF/Rev 3Y Avg | 8.4% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 21.2 |
| P/S | 2.4 |
| P/EBIT | 13.9 |
| P/E | 21.2 |
| P/CFO | 17.8 |
| Total Yield | 5.6% |
| Dividend Yield | 0.8% |
| FCF Yield 3Y Avg | 2.8% |
| D/E | 0.2 |
| Net D/E | 0.1 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | 5.1% |
| 3M Rtn | 6.6% |
| 6M Rtn | -19.9% |
| 12M Rtn | -8.1% |
| 3Y Rtn | -13.4% |
| 1M Excs Rtn | 5.5% |
| 3M Excs Rtn | 5.4% |
| 6M Excs Rtn | -28.4% |
| 12M Excs Rtn | -23.5% |
| 3Y Excs Rtn | -81.4% |
Price Behavior
Price Behavior
| Market Price | $2.08 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 02/16/2023 | |
| Distance from 52W High | -82.7% | |
| 50 Days | 200 Days | |
| DMA Price | $2.94 | $6.19 |
| DMA Trend | down | down |
| Distance from DMA | -29.3% | -66.4% |
| 3M | 1YR | |
| Volatility | 165.2% | 143.0% |
| Downside Capture | 441.26 | 212.80 |
| Upside Capture | -328.99 | 51.42 |
| Correlation (SPY) | 6.6% | 7.8% |
REED Betas & Captures as of 1/31/2026
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | -1.72 | -1.07 | 2.11 | 1.29 | 0.58 | 0.09 |
| Up Beta | -5.71 | 0.09 | 2.05 | 0.28 | 0.11 | 0.09 |
| Down Beta | -0.72 | -0.88 | 4.45 | 2.57 | 0.42 | 0.03 |
| Up Capture | 4% | -519% | -286% | -38% | 28% | -5% |
| Bmk +ve Days | 11 | 22 | 34 | 71 | 142 | 430 |
| Stock +ve Days | 9 | 16 | 22 | 48 | 106 | 313 |
| Down Capture | -362% | 276% | 397% | 188% | 137% | 79% |
| Bmk -ve Days | 9 | 19 | 27 | 54 | 109 | 321 |
| Stock -ve Days | 10 | 23 | 30 | 55 | 108 | 355 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with REED | |
|---|---|---|---|---|
| REED | -63.6% | 134.0% | -0.18 | - |
| Sector ETF (XLP) | 12.0% | 14.1% | 0.57 | -0.7% |
| Equity (SPY) | 16.3% | 19.3% | 0.65 | 6.6% |
| Gold (GLD) | 76.7% | 25.0% | 2.25 | 6.6% |
| Commodities (DBC) | 9.4% | 16.6% | 0.37 | 9.5% |
| Real Estate (VNQ) | 6.5% | 16.6% | 0.21 | 6.7% |
| Bitcoin (BTCUSD) | -27.3% | 44.7% | -0.58 | 15.2% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with REED | |
|---|---|---|---|---|
| REED | -58.0% | 104.5% | -0.39 | - |
| Sector ETF (XLP) | 8.8% | 13.1% | 0.45 | 2.3% |
| Equity (SPY) | 14.1% | 17.0% | 0.66 | 5.6% |
| Gold (GLD) | 22.1% | 16.9% | 1.06 | 6.0% |
| Commodities (DBC) | 11.3% | 18.9% | 0.48 | 5.4% |
| Real Estate (VNQ) | 5.3% | 18.8% | 0.19 | 4.6% |
| Bitcoin (BTCUSD) | 13.4% | 57.9% | 0.45 | 3.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with REED | |
|---|---|---|---|---|
| REED | -44.1% | 92.7% | -0.21 | - |
| Sector ETF (XLP) | 8.4% | 14.6% | 0.44 | 7.4% |
| Equity (SPY) | 15.7% | 17.9% | 0.75 | 12.1% |
| Gold (GLD) | 15.7% | 15.5% | 0.84 | 5.1% |
| Commodities (DBC) | 8.4% | 17.6% | 0.39 | 8.5% |
| Real Estate (VNQ) | 6.2% | 20.7% | 0.27 | 11.5% |
| Bitcoin (BTCUSD) | 68.8% | 66.7% | 1.08 | 4.9% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/4/2025 | -39.2% | -37.2% | -47.1% |
| 8/12/2025 | 5.7% | -1.9% | -3.8% |
| 3/27/2025 | 0.3% | 1.0% | 33.5% |
| 11/14/2024 | -10.4% | -36.8% | -47.8% |
| 8/13/2024 | 7.4% | -2.5% | -6.7% |
| 3/28/2024 | -3.1% | -4.3% | -20.2% |
| 11/9/2023 | -3.2% | -6.3% | -45.7% |
| 8/10/2023 | 8.3% | 8.3% | 22.4% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 6 | 4 | 3 |
| # Negative | 12 | 14 | 15 |
| Median Positive | 6.6% | 4.4% | 22.4% |
| Median Negative | -9.0% | -7.8% | -20.2% |
| Max Positive | 12.8% | 8.3% | 33.5% |
| Max Negative | -39.2% | -37.2% | -47.8% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/04/2025 | 10-Q |
| 06/30/2025 | 08/13/2025 | 10-Q |
| 03/31/2025 | 05/14/2025 | 10-Q |
| 12/31/2024 | 03/28/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/13/2024 | 10-Q |
| 03/31/2024 | 05/20/2024 | 10-Q |
| 12/31/2023 | 04/01/2024 | 10-K |
| 09/30/2023 | 11/09/2023 | 10-Q |
| 06/30/2023 | 08/10/2023 | 10-Q |
| 03/31/2023 | 06/01/2023 | 10-Q |
| 12/31/2022 | 05/15/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/15/2022 | 10-Q |
| 03/31/2022 | 05/16/2022 | 10-Q |
| 12/31/2021 | 04/15/2022 | 10-K |
Insider Activity
Expand for More| # | Owner | Title | Holding | Action | Filing Date | Price | Shares | Transacted Value | Value of Held Shares | Form |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Era, Regenerative Medicine Ltd | See footnote | Buy | 6102025 | 0.00 | 1,075,269 | Form |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.